Celltrion Archives | Page 2 of 2 | Be Korea-savvy
Celltrion’s Truxima Has 30 pct Market Share in Britain

Celltrion’s Truxima Has 30 pct Market Share in Britain

SEOUL, Aug. 1 (Korea Bizwire) — An affiliate of South Korean biopharmaceutical firm Celltrion Inc. said Tuesday that its biosimilar drug Truxima accounts for 30 percent of the Britain market. Truxima, a reference to Roche’s Mabthera, also known as Rituxan, has become a presence in the European country since its launch in April, Celltrion Healthcare [...]

Gov’t to Nurture Manpower in Bio Industry

Gov’t to Nurture Manpower in Bio Industry

SEOUL, Apr. 12 (Korea Bizwire) — South Korea is set to release a set of support measures, including nurturing talented manpower, to help local pharmaceutical companies make further inroads into the global market, the country’s health minister said Tuesday. The remarks were made during a meeting attended by Health Minister Chung Chin-yeob, and executives of [...]

Celltrion to Expand Presence in U.S. With FDA’s New Guidance

Celltrion to Expand Presence in U.S. With FDA’s New Guidance

SEOUL, Jan 19 (Korea Bizwire) – The U.S. Food and Drug Administration (FDA) has released its draft guidance on biosimilar interchangeability, a move that will allow South Korean bio-pharmaceutical firm Celltrion Inc. to increase its presence in the U.S. market, company officials said Thursday.  The FDA unveiled the guidance Tuesday (local time) that recommends that [...]

S. Korea’s Biomedicine Exports Top US$1 Bln in 2016: Data

SEOUL, Jan. 18 (Korea Bizwire) – Biomedicine exports by South Korean pharmaceutical firms jumped more than 50 percent in 2016 from a year earlier to surpass the US$1 billion mark for the first time, data showed Wednesday.  Outbound shipments of locally manufactured biomedicines such as vaccines and genetic recombination drugs stood at US$1.44 billion last [...]